Concepedia

Jean Luc Breton

JL

Statistics

Publications

4

Citations

208

H-Index

4

Active since

2003

Affiliations

Centre Hospitalier Départemental Vendée(Current)

Jean Luc Breton is an author at Centre Hospitalier Départemental Vendée specializing in oncology, medicine, and medical oncology.

Publications per year

2003–2007

4

Publications

4

Phase III Double-Blind, Placebo-Controlled Study of Thalidomide in Extensive-Disease Small-Cell Lung Cancer After Response to Chemotherapy: An Intergroup Study FNCLCC cleo04–IFCT 00-01

Jean Louis Pujol, Jean Luc Breton, Radj Gervais et al. · Journal of Clinical Oncology · 2007 · 143 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

O-082 A randomized phase III trial comparing ionafarnib/carboplatin/paclitaxel versus carboplatin/paclitaxel (CP) in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)

George R. Blumenschein, Carrianne Ludwig, Glyn Thomas et al. · Lung Cancer · 2005 · 24 citations

Medicine, Oncology, Pharmacology +14

Lung cancer among women in France.

M Grivaux, Jean Luc Breton, P. Bombaron et al. · Lung Cancer · 2004 · 23 citations

Medicine, Oncology, Cancer Control +8

O-3 Randomized phase II study of the novel tubulin targetin agent, BMS-247550 (Epothilone B analogue) in the treatment of non-small cell lung cancer (NSCLC) in patients (pts) who have failed first line platinum containing therapy

Martin J. Edelman, Jean Luc Breton, Alan N. Sandler et al. · Lung Cancer · 2003 · 18 citations

Medicine, Oncology, Pharmacology +16

1–4 of 4